• Facebook
  • Instagram
  • TikTok
  • Mastodon
  • YouTube
  • X
  • Twitch

Scientific Inquirer

  • Everyday Science.
  • Left Brain/Right Brain.
  • Sports.
  • Features.
  • About.
  • Contact.

drug trials

  • New ACP guideline on migraine prevention shows no clinically important advantages for newer, expensive medications
    May 1, 2025

    New ACP guideline on migraine prevention shows no clinically important advantages for newer, expensive medications

    bricemarsters
  • Scientists hack cell entry to supercharge cancer drugs
    April 25, 2025

    Scientists hack cell entry to supercharge cancer drugs

    bricemarsters
  • Study highlights need for improvement of patient safety in outpatient settings
    May 11, 2024

    Study highlights need for improvement of patient safety in outpatient settings

    bricemarsters
  • Study eases concern at antipsychotics use in pregnancy
    April 18, 2024

    Study eases concern at antipsychotics use in pregnancy

    bricemarsters
  • Delivering on the promise of personalized breast cancer therapy
    May 24, 2023

    Delivering on the promise of personalized breast cancer therapy

    bricemarsters
  • Bad medical news causes patients to choose brand name drugs over generics, costing billions
    April 23, 2023

    Bad medical news causes patients to choose brand name drugs over generics, costing billions

    bricemarsters
  • Multiple sclerosis discovery could end disease’s chronic inflammation
    February 22, 2023

    Multiple sclerosis discovery could end disease’s chronic inflammation

    bricemarsters
  • Good news for quality control of messenger RNA (mRNA) medications
    February 16, 2023

    Good news for quality control of messenger RNA (mRNA) medications

    bricemarsters
  • Cochrane Review finds that vitamin D does not reduce risk of asthma attacks
    February 10, 2023

    Cochrane Review finds that vitamin D does not reduce risk of asthma attacks

    bricemarsters
  • Genomic methods aid study of Seattle 2017-2022 Shigella outbreak
    February 3, 2023

    Genomic methods aid study of Seattle 2017-2022 Shigella outbreak

    bricemarsters
1 2
Next Page

Categories

Asia.

North America.

Europe.

Africa.

South America.

Australia.

Science For All, Not Just The Few.

Subscribe to our newsletters. We’ll keep you in the loop.

  • Facebook
  • Instagram
  • TikTok
  • Mastodon
  • YouTube
  • X
  • Twitch
  • Everyday Science.
  • Left Brain/Right Brain.
  • Sports.
  • Features.
  • About.
  • Contact.

Designed with WordPress

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
 

Loading Comments...